Has This Top Marijuana Stock Weathered a Serious Storm?

By:
Has This Top Marijuana Stock Weathered a Serious Storm?

Pixabay / Goumbik / CC0 Creative Commons

The stock of MedReleaf Corp. (TSX:LEAF) has recently outperformed those of other top marijuana stock players in Canada, and there could be further price gains going forward after the recently listed cannabis firm has found its footing and stopped the earlier quarterly revenue declines.

As previously discussed here, MedReleaf’s quarterly revenues suffered sequential declines since the quarter ended September 30, 2016; it picked at $10,475,000 before bottoming out at $10,360,000 during the quarter ended March 31, 2017.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top